Medtronic: Adverse Event Reports Raise Questions About Company’s Device Safety Claims, Regulator’s Oversight

Published on Mar 15, 2024

Adverse event reports received by the Food and Drug Administration and released to the public on a monthly basis continue to raise questions about the agency’s ability to ensure medical device safety, a Capitol Forum review of data related to implantable cardiac rhythm devices manufactured by device maker Medtronic (MDT) has found.

Already have an account? Log in.

This article is currently locked and only available to subscribers. Request a trial to receive unlimited access to all articles.

View Only Unlocked Articles

© 2024 the Capitol Forum